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Abstract
As a nitric oxide (NO) enhancer, citrulline malate (CM) has recently been touted as a potential ergogenic aid to both resist-
ance and high-intensity exercise performance, as well as the recovery of muscular performance. The mechanism has been 
associated with enhanced blood flow to active musculature, however, it might be more far-reaching as either ammonia 
homeostasis could be improved, or ATP production could be increased via greater availability of malate. Moreover, CM 
might improve muscle recovery via increased nutrient delivery and/or removal of waste products. To date, a single acute 8 g 
dose of CM on either resistance exercise performance or cycling has been the most common approach, which has produced 
equivocal results. This makes the effectiveness of CM to improve exercise performance difficult to determine. Reasons for 
the disparity in conclusions seem to be due to methodological discrepancies such as the testing protocols and the associated 
test–retest reliability, dosing strategy (i.e., amount and timing), and the recent discovery of quality control issues with some 
manufacturers stated (i.e., citrulline:malate ratios). Further exploration of the optimal dose is therefore required including 
quantification of the bioavailability of NO, citrulline, and malate following ingestion of a range of CM doses. Similarly, 
further well-controlled studies using highly repeatable exercise protocols with a large aerobic component are required to 
assess the mechanisms associated with this supplement appropriately. Until such studies are completed, the efficacy of CM 
supplementation to improve exercise performance remains ambiguous.
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Abbreviations
CM  Citrulline malate
NO  Nitric oxide
ATP  Adenosine triphosphate
MAS  Malate aspartate shuttle
MDH  Malate dehydrogenase
NIRS  Near infrared spectroscopy
PFK  Phosphofructokinase
TCA  Tricarboxylic acid
HR  Heart rate
GI  Gastrointestinal
GVT  German volume training
VO2peak  Peak oxygen consumption
EMG  Electromyography
Introduction
Considerable research attention has recently been placed 
on the physiological signalling molecule, nitric oxide 
(NO) (Jones et  al. 2020). Augmenting NO synthesis 
through exogenous substances may improve skeletal mus-
cle function and performance through improved blood 
flow, contractility, and mitochondrial respiration (Stam-
ler and Meissner 2001). Typical strategies to increase 
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NO activity include the ingestion of green leafy vegeta-
bles and/or beetroot juice and L-citrulline (Jones 2020). 
Indeed, L-citrulline is known to exert positive effects on 
exercise performance and recovery (Gonzalez and Trex-
ler 2020). More recently, however, a direct NO precursor 
called citrulline malate (CM) has been touted to have ergo-
genic potential, which is the combination of L-citrulline 
and malate (Gonzalez and Trexler 2020). The mechanisms 
of CM might be more far-reaching as a result, due to the 
synergistic impact of both components (i.e., L-citrulline 
and malate) at the intramuscular level (Wax et al. 2015). 
Specifically, malate has been suggested to increase the rate 
of ATP production by mitigating lactate production during 
states of high flux; and by doing so allowing for contin-
ued pyruvate and energy production (Wax et al. 2016). 
Furthermore, the malate-aspartate shuttle (MAS) may be 
more efficient following CM ingestion, thereby improving 
ATP availability (Wu et al. 2007; Agudelo et al. 2019). 
Based on these promising findings and additional mecha-
nisms compared to L-citrulline supplementation alone, it 
is plausible to suggest CM supplementation could be a 
worthwhile ergogenic aid.
Since the early work of Bendahan et al. (2002), research 
has primarily focused on the potential ergogenic effects of 
CM supplementation on resistance exercise performance. 
In an early study, a greater contribution of oxidative ATP 
synthesis (34% increase) to energy production was observed 
with chronic ingestion of CM for 15 days (6  g.day) (Brenda-
han et al. 2002). This study, however, focused on sedentary 
individuals who complained of fatigue and included no pla-
cebo condition and therefore, the application to athletes is 
limited. Nonetheless, recent work has addressed these limi-
tations and investigated acute doses of CM against a pla-
cebo and the associated effects on short-term exercise that 
encompasses a large anaerobic component in trained and 
untrained individuals. To date, equivocal responses to CM 
supplementation have been reported, which makes the per-
formance-enhancing potential ambiguous. Moreover, CM 
ingestion could improve acute recovery from exercise due 
to the augmentation of blood flow and the indirect increase 
in nutrient delivery and clearance of waste metabolites (Wax 
et al. 2015; Glenn et al. 2017). This could have important 
implications for athletes who may have minimal recovery 
from competition/training due to the high frequency of exer-
cise bouts in their schedules (e.g., team sports, track and 
field). This review therefore builds upon a previous review 
by Gonzalez and Trexler (2020) who recently discussed 
the efficacy CM ingestion to improve exercise performance 
within a larger, more general review of NO enhancing sup-
plements, by offering a more in-depth discussion on the 
potential mechanisms associated with CM supplementa-
tion. This is followed by a discussion of findings to date in 
respect of improving exercise performance and/or recovery, 
including modifying factors such as the exercise type and 
duration, ingestion strategy (dose and timing), and the safety 
of CM supplementation.
Proposed ergogenic mechanisms
The ingestion of CM was originally prescribed to enhance 
the muscle performance of patients suffering from asthenia 
and to facilitate the recovery of muscle function resulting 
from acute diseases (Brendahan et al. 2002). As an organic 
salt, CM and is formed through the combination of L-citrul-
line  (C6H13N3O3), a non-essential amino acid involved in the 
urea cycle, and malate (or malic acid,  C4H6O5), a tricarbox-
ylic acid (TCA) intermediate (Bendahan et al. 2002; da Silva 
et al. 2017; Glenn et al. 2017; Wax et al. 2015). Outside of 
the common practice of oral supplementation of beetroot 
juice, L-citrulline ingestion has been the most researched 
nutritional strategy to stimulate NO production (Gonzalez 
and Trexler, 2020). This is likely explained by studies that 
show L-citrulline ingestion to be the most efficient means 
of elevating plasma arginine concentrations, which in turn, 
produces NO (Schwedhelm et al. 2008).
The proposed mechanism for CM ingestion is firstly 
dependent on the citrulline component via the L-arginine-
NO pathway, such that following NO synthesis the smooth 
muscle may relax leading to vasodilation (Vanhoutte et al. 
2016; Fig. 1). In turn, these vasodilatory properties may 
improve the delivery of blood (and oxygen) to and from the 
active musculature during exercise (Wax et al. 2015). Trexler 
and colleagues (2019a, 2019b) have recently questioned this 
mechanism, however, using the near-infrared spectroscopy 
(NIRS) technique to quantify blood flow. Indeed, Trexler 
et al. (2019a) reported 8 g CM ingestion 2 h prior to exer-
cise had no effect on muscle blood flow (CM: 3.78 ± 0.26, 
placebo: 3.72 ± 0.26 ml.min−1.100  ml−1) or oxygen con-
sumption (CM: 1.15 ± 0.11, placebo: 1.16 ± 0.11  mLO2.
min−1.100  g−1) during 3 min of leg extension exercise (one 
rep every 4 s). These findings were replicated during maxi-
mal effort leg extension exercise consisting of 5 sets of 30 
maximal-effort concentric leg extensions interspersed with 
1 min of passive rest between sets (Trexler et al. 2019b). 
The authors findings were likely due to the small rises in 
NO observed in these studies, as they were not signifi-
cantly different to the placebo (CM: 15.3 ± 1.1; placebo: 
13.4 ± 1.1 μmol·L; Trexler et al. 2019b). Alternatively, the 
failure to select a dynamic whole-body exercise might have 
led to no improvement, as this might not have sufficiently 
stressed the aerobic mechanisms associate with inges-
tion of this supplement. Finally, whilst the use of NIRS is 
widely considered a reliable technique (Lucero et al. 2018), 
it is unclear if this technique is sensitive enough to detect 
changes following supplement intake. The evidence to date 
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specifically on CM supplementation suggests that enhanced 
blood flow caused by the citrulline component is not the 
acting mechanism, although further experimental research 
is required.
An alternative mechanism could be from the citrulline 
component of CM, as this may assist with ammonia elimi-
nation during the urea cycle (Bendahan et al. 2002; Fig. 1). 
This is important due to the increased ammonia production 
observed during high-intensity exercise, and the associa-
tion of these changes with muscle fatigue (Gonzalez and 
Trexler 2020). Specifically, high ammonia concentrations 
facilitate the production of lactate during anaerobic glyco-
lysis by activating phosphofructokinase (PFK). In turn, this 
prevents oxidative metabolism of pyruvate to acetyl-CoA 
and hinders the ATP supply to skeletal muscle (Hargreaves 
and Spriet 2020). Citrulline may exert its ergogenic effects 
through this mechanism by detoxifying ammonia dur-
ing high-intensity exercise, thereby enhancing the aerobic 
utilization of pyruvate and ATP supply to skeletal mus-
cle (Gonazalez and Trexler, 2020). Indeed, Takeda et al. 
(2011) reported ingestion of citrulline (250 mg.kg−1 BM) 
reduced ammonia accumulation by 90.1 µg/dL−1 (citrulline: 
351.3 ± 35.3 vs. control: 441.4 ± 61.3 µg.dL−1) and increased 
time to exhaustion swimming by approximately 9 min in 
mice (citrulline = 24 min, placebo = 15 min). Importantly, 
post-exercise lactate concentrations were lower for the 
citrulline-supplemented group, which in turn, supports the 
mechanism of enhancing aerobic utilization during exercise. 
This has not been replicated in humans, however, and as 
such, it remains to be confirmed if this mechanism occurs 
during human exercise.
Greater ergogenic benefits may be possible in addition 
to the L-citrulline mechanisms with the addition of malate 
(Fig. 2). The primary role of malate is to function as a tricar-
boxylic acid cycle intermediate, which may play an impor-
tant role in the rate of ATP production (Brendahan et al. 
2002). One of the most critical controls of the rate of aerobic 
ATP production is oxaloacetate, and as malate is dehydro-
genated into this compound in the TCA cycle, it may offer 
an explanation to the purported additive effects of CM over 
L-citrulline alone (Brendahan et al. 2002). Equally, malate 
is suggested to play a critical role (amongst four other TCA 
intermediates) in ancillary reactions that can alter the con-
centrations of TCA intermediaries and result in positively 
affecting the fluxes in and out of the TCA cycle (Gibala et al. 
2000). Whilst these mechanisms sound promising, no study 
to date involving CM supplementation and exercise perfor-
mance has provided evidence of these mechanisms occur-
ring. Admittedly, this is difficult given the complexities and 
lack of measurement techniques, and most evidence support-
ing this theory to date is based on mathematical approaches/
modelling. It is not possible therefore to confirm at this time 
whether they are important during exercise. Nonetheless, 
the synergistic mechanisms of L-citrulline and malate (i.e., 
CM) do offer hope that these mechanisms could synergisti-
cally improve exercise performance. Future research should 
directly compare L-citrulline vs. CM ingestion to assess if 
the addition of malate does offer additive benefits to exercise 
performance.
A contemporary mechanism may be either through 
the increase in gene expression, or increased efficiency 
of the MAS, which is caused by elevations in PGC-1α in 
Fig. 1  A schematic repre-
sentation of the mechanisms 
associated with citrulline 
malate supplementation. Bold 
denotes the active ingredient. 
Left: NO-derived mechanism, 
Right: Ammonia clearance 
mechanism. *Denotes evidence 
is either speculative or has 
only been observed in mice. 
(Schematic created in BioRen-
der.com)
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exercising musculature. These physiological changes can 
elevate aspartate and glutamate levels and increase the 
expression of glycolysis and MAS genes (Wu et al. 2007; 
Agudelo et al. 2019). As a result, increases in the transfer 
of fuel-derived electrons to mitochondrial respiration may 
occur, which in theory, should improve energy utilisation 
(Wu et al. 2007; Fig. 2). Indeed, evidence in mice has shown 
that supplementation of L-malate increased the activity of 
malate dehydrogenase (MDH) in a dose–response man-
ner, as higher doses reported more activity (Control mice: 
15.7 ± 2.4 vs. 0.2 g.kg−1  BM.day−1 dose: 24.3 ± 3.5 vs. 0.6 g.
kg−1  BM.day−1 dose: 26.4 ± 3.7) (Wu et al. 2007). Mecha-
nistically, as MDH is a rate-limiting enzyme for MAS, an 
increase in activity could suggest an increase in efficiency 
and therefore ATP supply. Similarly, MDH yields oxaloac-
etate by dehydrogenating L-malate to increase overall rates 
of TCA flux and MAS. Support for these mechanisms can 
be found in Wu et al. (2007), such that time to exhaustion 
swimming was improved in both the 0.2 g.kg−1  BM.day−1 g 
(+ 26.1%; 620 ± 141  s) group and 0.6 g.kg−1  BM.day−1 
(+ 28.5%; 631 ± 134 s) versus the control (491 ± 145 s). 
However, no data is available from using human participants 
to corroborate these findings in mice, whilst Wu et al. (2007) 
also chronically supplemented L-malate, not CM. Further 
research in humans is therefore required to confirm this 
mechanism.
Supplementation of CM is suggested to reduce muscle 
soreness from exercise, via the purported increased blood 
flow mechanism (Wax et al. 2015; da Silva et al. 2017). This 
could be important for either subsequent performance when 
recovery between bouts is limited (i.e., track and field) and/
or overall quality and quantity of chronic training. In a large 
study of forty-one men, ingestion of 8 g CM 1 h before a 
resistance training bout led to decreases in muscle soreness 
at both 24 h (-40%) and 48 h (-41%), respectively, compared 
to a placebo (Perez-Guisado et al. 2010). However, there was 
no subsequent performance bout to substantiate whether the 
reduction in soreness translates to improved performance. 
In a more thorough study (da Silva et al. 2017), CM supple-
mentation (6 g, 1 h before exercise) failed to improve muscle 
soreness when more reporting points (24, 48, and 72 h) were 
used compared to Perez-Guisado et al. (2010). Importantly, 
da Silva et al. (2017) also reported no improvement in sub-
sequent performance for neither leg press exercise, nor hack 
Fig. 2  A schematic representation of the mechanisms associated with 
citrulline malate supplementation. Bold denotes the active ingredient. 
Left: Increased bioavailability of malate mechanism, Right: Increased 
efficiency of Malate Aspartate Shuttle (MAS). *Denotes evidence is 
either speculative or has only been observed in mice. (Schematic cre-
ated in BioRender.com)
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squat to exhaustion. Whilst the lack of differences observed 
could be attributed to the low 6 g dose adopted by da Silva 
et al. (2017), a more recent study has corroborated these 
findings using an 8 g dose, 1 h before exercise (Chappel et al. 
2018). Based on the current evidence that CM supplementa-
tion does not enhance blood flow and thereby increase nutri-
ent delivery and/or remove waste metabolites, this might 
explain why no positive impact has been reported to date 
for muscle soreness and subsequent exercise performance.
Dose, timing, and safety
The most commonly employed dose of CM is a single acute 
8 g dose (Gonzalez and Trexler 2020), which appears to 
reflect early work observing performance benefits during 
resistance exercise using this dose (Perez-Guisado et al. 
2010; Table 1). However, an earlier dose–response study 
(Moinard et al. 2008) investigated the pharmacokinetics of 
2, 5, 10, and 15 g of citrulline within eight healthy vol-
unteers and demonstrated that larger doses could be more 
appropriate. The authors reported that peak citrulline con-
centration occurred with a 15 g dose (3849 ± 190 μmol.l−1), 
which was significantly higher (+ 28.4%) compared to 10 g 
citrulline (2756 ± 170 μmol.l−1). It is plausible such larger 
doses (i.e., > 10 g) will increase the likelihood of securing 
an ergogenic benefit during exercise, which questions the 
use of a 8 g dose in most research to date. It is worth not-
ing, however, that Moinard et al. (2008) only used citrul-
line, rather than the combined intake of CM. The extent 
to which the malate may influence the peak concentration 
and pharmacokinetics is therefore currently unknown and 
warrants further investigation. Indeed, to achieve an intake 
of 10 g of L-citrulline, ingestion of around 3–5 kg of fresh 
watermelon (highest concentration of all foods) would be 
required and this is not only impractical for athletes (Davis 
et al. 2011), but would also not contain a sufficient dose of 
the malate component. Given the large dose required for any 
possible ergogenic effect, supplementation is only practi-
cal via ingestion of marketed sports supplements or the raw 
chemical compound.
There appears to be limited diversity in the timing of CM 
ingestion with most studies opting for 1-h ingestion before 
exercise (Gonzalez and Trexler 2020). This approach seems 
to be informed by previous research reporting ergogenic 
effects using similar dosing strategies (Wax et al. 2015, 
2016; Farney et al. 2019), rather than the time to reach peak 
concentrations of citrulline (Moinard et al. 2008; Cunniffe 
et al. 2016). Few studies investigating exercise performance 
have included concomitant measurements of peak plasma 
citrulline, which is likely due to the cost of such procedures. 
Indeed, Cunniffe et al. (2016) reported that following 12 g 
of CM plasma citrulline concentration was 343 ± 41 µM, 
compared to 39 ± 12 µM following the placebo. A similar 
magnitude of change was also observed for plasma ornithine 
concentration (9.5 ± 3.1 µM vs. 2.4 ± 1.6 µM). However, the 
time-course changes in these markers cannot be determined, 
as only a single blood sample was taken at 60 min. Equally, 
the 12-g dose ingested was higher than that typically used 
in CM research, therefore the changes in plasma citrulline 
concentration following the most common 8 g dose are 
unknown. Nonetheless, a study by Moinard et al. (2008) 
reported that following a range of doses of citrulline (2, 5, 
10, and 15 g), peak concentration of citrulline occurred at 
approximately 1 h, however, this rapidly declined 15–30 min 
after the initial peak regardless of the dose ingested. Both 
plasma arginine and ornithine also displayed a similar pat-
tern of peak and clearance. Further research investigating 
time-course changes in citrulline concentration following 
CM supplementation is required to determine the optimal 
strategy, although the best recommendation at the moment 
would be 1 h prior to exercise. It can also be concluded that 
the ‘ergogenic window’ is likely to be small and therefore 
determination of the peak absorption characteristics are 
likely to be important to securing an ergogenic benefit.
Most research investigating CM ingestion and exercise 
performance reports that a 2:1 ratio of citrulline:malate has 
been used. Recent research has challenged these reports, 
however, such that many CM manufacturers failed to reach 
the purported ratios (Chappel et al. 2018). Importantly, the 
ratios reported in a study using nuclear magnetic resonance 
spectroscopy reported most nutritional companies/suppliers 
only provided a CM ratio of approximately 1.6:1, with some 
as low as 1.1:1 (Chappel et al. 2018). Based on ingesting 
8 g of CM with a 1.1:1 ratio, individuals are only ingesting 
4.2 g instead of 5.3 g (the latter based on a 2:1 ratio). These 
potential quality control issues have ramifications for the 
existing body of work, future research, and its use by athletes 
in practice. Based on multiple studies using citrulline in iso-
lation and reporting ergogenic effects (Gonzalez and Trexler 
2020), it is likely the citrulline component of CM is vital to 
secure ergogenic benefits. It is plausible as a result that the 
equivocal findings in respect of CM ingestion and exercise 
performance could also be partly attributed to the amount 
of ingested citrulline being lower than intended. Research-
ers should therefore consider an independent assessment 
of supplement quality and authenticity to be able to gain 
assurances the dose ingested is as intended. If an independ-
ent assessment is not available, based on the findings from 
Chappel et al. (2018) only Trade Ingredients (www. trade 
ingre dients. com) were close to the required ratio, and there-
fore this is the best-known source at this time.
The effects of citrulline supplementation on biomark-
ers associated with health outcomes have been previously 
investigated; however, limited evidence on CM exists. 
Indeed, Moinard et al. (2008) reported that ingestion of a 
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range of doses between 2–15 g of citrulline had no adverse 
effect on hematological markers (leucocytes, polymorpho-
nuclears, lymphocytes, monocytes, erythrocytes, Hb) or 
biochemical markers (calcium, total proteins, albumin, 
C-reactive protein, urea, creatinine, glucose, cholesterol, 
triacylglycerol). Unfortunately, no study as comprehensive 
as the Moinard et al. (2008) study exists for CM supple-
mentation, although a small amount of research has stud-
ied health outcomes alongside supplementation (Brenda-
han et al. 2002; Casonatto et al. 2019). Indeed, Brendahan 
et al. (2002) supplemented CM chronically at 6  g.day−1 for 
15 days, in a group of 18 sedentary males and reported 
no negative experiences. No objective health markers 
were measured, however, and the reports were subjective 
views from the authors. Casonatto et al. (2019), however, 
reported that following supplementation of 6 g of CM, 
both diastolic and systolic blood pressure was reduced 
over a 24-h period following exercise (40-min run/walk 
at 60–70% HR reserve) within a group of 40 hypertensive 
individuals. The applications of these findings would be 
difficult to apply to athletes, as they are likely to undertake 
more routine ingestion of CM compared to hypertensive 
patients. Considering the studies to date have only used 
an acute dose, and not used trained athletes, the safety 
of longer-term supplementation of CM requires further 
investigation. It is worth noting, however, that generally 
the ingestion of nitrate-based supplements are considered 
safe for consumption (Sindelar et al. 2012).
A common issue with ingestion of amino acids is the 
onset of gastrointestinal (GI) discomfort, whereby vomit-
ing and diarrhea have been reported following ingestion 
of related amino acids such as arginine and ornithine in 
doses of between 6 and 12 g (Grimble 2007). Notably, 
the side effects reported with CM supplementation seem 
to be less severe. Indeed, Glenn et al. (2017) reported no 
differences in GI discomfort between CM supplementa-
tion and placebo following acute ingestion of 8 g within 
resistance-trained females, whilst larger doses of 12 g also 
seemed to be well-tolerated within a group of trained male 
cyclists (Cunniffe et al. 2016). These differences could be 
related to different mechanisms of citrulline uptake, such 
that it can be taken up from the lumen by multiple trans-
port systems, including  B0,+ (Bahri et al. 2008). In com-
parison, arginine and ornithine are rapidly saturated within 
the intestine and can therefore induce osmotic diarrhea. 
Moreover, these factors could explain why citrulline seems 
to have increased bioavailability compared to similar com-
pounds, such as arginine (Breuillard et al. 2015; Moinard 
et al. 2008) and why larger doses can be tolerated. The 
findings for CM supplementation are therefore promising 
for real-world application in a performance setting, as no 
study to date has reported any significant GI discomfort 
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Effects of citrulline malate on exercise 
performance
Initial investigations have demonstrated that a single acute 
8 g dose of CM ingested 1 h before exercise can enhance 
dynamic muscular endurance and strength performances, 
within resistance-trained males and females (Gonzalez and 
Trexler, 2020; Table 1). Perez-Guisado et al. (2010) used 
41 resistance-trained males to perform four sets of barbell 
bench press at 80% 1RM (1-min rest between sets) follow-
ing ingestion of 8 g CM, 1-h prior to exercise. Repetitions 
to failure in all but the first two sets of bench press before 
the workout were improved following CM ingestion. Per-
formance responses have been replicated in resistance-
trained females whilst performing six sets of bench press 
and plate-loaded leg press exercise at 80% 1RM (1-min 
rest between sets) using a similar dosing strategy (Glenn 
et al. 2017). Furthermore, in a series of investigations by 
Wax and colleagues (2015, 2016), ingestion of 8 g of CM 
1-h before exercise increased the repetitions to failure dur-
ing leg press and hack squat at 60% 1RM, and in a series of 
bodyweight exercises (chin-ups, push-ups), respectively. 
These changes were only subtle across these studies when 
expressed as an effect size (range: 0.23–0.59), which could 
suggest that CM’s ergogenic action might be more modest 
in such settings. Nonetheless, these small improvements 
across multiple sessions might improve training adaptation 
across a training block.
In contrast to the preliminary investigations assessing 
the ergogenic effects of CM supplementation on resist-
ance exercise, no benefit to German Volume Training 
(GVT) protocols has been reported (Chappell et al. 2018a, 
2018b). The ingestion of 8 g CM 1 h before exercise did 
not influence the total number of repetitions to failure dur-
ing barbell curls (10 × 10 repetitions at 80% 1RM) (Chap-
pell et al. 2018a) or isokinetic dynamometer leg curls 
(10 × 10 repetitions at 70% of concentric maximum force, 
1-min rest between sets) (Chappell et al. 2018b). The lat-
ter protocol also showed no change in maximal isometric, 
concentric and eccentric force using this dosing strategy. 
Mitigating factors to explain the lack of performance 
improvement could be either the use of a CM compound 
disproportionate to the target ratio of citrulline and malate, 
or the reliability of the exercise protocol. Specifically, both 
studies by Chappell and colleagues (2018a, b) reported 
that the citrulline:malate ratio in the CM administered to 
participants was much lower than purported by the manu-
facturer (2:1 vs. 1.1:1). This equates to only around half 
of the stated dose of citrulline, which in turn, may have 
reduced the ergogenic potential. Lastly, GVT resistance 
training protocols do not seem to have any established 
test–retest reliability to date, which makes it difficult to 
determine small but meaningful changes in performance.
Some studies also confer no ergogenic effects of CM 
ingestion on dynamic or isokinetic muscular power indi-
ces (Farney et al. 2019; Gonzalez et al. 2018; Trexler et al. 
2019a, 2019b). Indeed, Gonzalez et al. (2018) used a lin-
ear position transducer to examine the influence of 8 g CM 
(40 min before exercise) on power indices whilst performing 
5 sets of up to 15 repetitions of barbell bench press exercise 
at 75% 1RM (2-min rest between sets). The authors reported 
no effect on peak power, mean power, fatigue index, or total 
repetitions performed by the group of resistance-trained 
males (n = 12). These findings agree with arguably the most 
comprehensive study to date by Trexler et al. (2019a) report-
ing ingestion of 8 g CM 2 h before exercise had no impact 
on peak torque, average torque, or total work during 5 sets of 
30 maximal effort, concentric leg extensions (180°·s; 1-min 
rest between sets) compared to a placebo. The authors also 
reported no mechanistic evidence to suggest CM improves 
blood flow, metabolic efficiency, or lactate clearance. These 
findings have been corroborated during submaximal isotonic 
concentric leg extensions at 25% of maximal voluntary con-
traction torque (Trexler et al. 2019b). A caveat to both Gon-
zalez et al. (2018) and Trexler et al. (2019a; b) might be the 
ingestion timing of CM however, as both were outside of the 
1-h before exercise timing used in studies reporting a posi-
tive effect on performance or where data suggests peak NO 
occurs (Moinard et al. 2008). Furthermore, it is unknown if 
the mechanisms of action would have been observed during 
full-body dynamic exercise where there is a higher aerobic 
and metabolic demand, as CM ingestion seems to be more 
appropriate for this type of exercise (see proposed ergogenic 
mechanisms section).
Positive effects of CM ingestion on cycling performance 
are scarce, with only three studies to date employing a ran-
domised, placebo-controlled crossover study design (Glenn 
et al. 2017; Cunniffe et al. 2016; Gills et al. 2021). Indeed, 
Glenn et al. (2017) showed that 8 g of CM 1-h before exer-
cise failed to improve mean power output or fatigue index 
during a cycling Wingate, within a group of 17 trained ten-
nis players. Similarly, Cunniffe et al. (2016) observed no 
improvement during 10 × 15 s cycling sprints (30 s active 
recovery) despite the use of a higher 12 g dose of CM 1-h 
before exercise. The short-duration exercise protocols in 
these studies do not investigate the more aerobically derived 
mechanisms associated with CM supplementation, how-
ever, and this could explain the lack of ergogenic benefit. 
Nonetheless, in a contemporary study (Gills et al. 2021) 
employing a time to volitional tolerance  (TLIM) protocol at 
a much lower exercise intensity (90%  VO2peak), no improve-
ment in cycling capacity was observed between ingestion 
of 8 g CM versus a placebo, within a group of 28 males 
(p = 0.94; PLA: 315.4 ± 137.7  s; CM: 314.1 ± 107.1  s). 
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It is plausible that the lack of ergogenic effects could be 
attributed to the trained participant cohort in the cycling 
studies  (VO2peak range = 56.3 – 58.1 ml.kg−1.min−1), such 
that a recent point-counterpoint debate suggests due to an 
elevated NO at baseline compared to their untrained counter-
parts this could blunt the ergogenic effect (Hultström et al. 
2015). Alternatively, the variation that is typically seen dur-
ing  TLIM tests could explain the null effect, as these protocols 
require a large difference in performance to reach statistical 
significance compared to either fixed duration or distance 
time trials (Currell and Jeukendrup 2008). Considering these 
studies utilised the same dose and timing of ingestion as 
other studies demonstrating ergogenic effects in resistance 
exercise performance, the use of CM seems ineffective at 
improving cycling performance in trained individuals. None-
theless, future research should combine CM ingestion and a 
time trial cycling bout with a predominantly aerobic demand 
to ascertain if a competitive edge could be gained.
Few studies have considered the ergogenic potential of 
CM supplementation in supporting the recovery of muscle 
function (da Silva et al. 2017) and/or adaptive properties of 
musculature in humans (Hwang et al. 2018a, b) (Table 1). 
Specifically, chronic supplementation of either 2 g of CM, 
2  g L-citrulline, and 200  mg glutathione, or a placebo 
(2.52 g cellulose) per day over 8 weeks did not affect maxi-
mal muscular strength development (via bench press and 
leg press exercises) (Hwang et al. 2018a, b). Interestingly, 
whilst no significant difference was found, a large effect size 
(Hedges g = 1.8) was reported for reductions in fat mass at 
8 weeks. A possible explanation for the null effect on per-
formance and/or adaptation may be that the CM dose was 
too low, as this was significantly reduced compared to the 
dose typically used to produce ergogenic effects (2 g vs 8 g). 
However, this dose may be sufficient to help with a reduction 
in fat mass and therefore support overall athlete body com-
position. With this being the only study to date investigating 
chronic ingestion of CM, more research is required using 
higher doses that might subsequently improve the probabil-
ity of securing any potential benefit to exercise performance 
and/or body composition.
A study investigating acute recovery from exercise has 
displayed null effects of CM supplementation (da Silva 
et al. 2017). The authors reported ingestion of 6 g of CM 
1-h before exercise had no impact on the recovery of lower 
limb muscular endurance (one set at 100% of 10 RM leg 
press and hack squat), markers of muscle damage (creatine 
kinase), or electromyographic (EMG) activation compared 
to a placebo at 24, 48 and 72 h post-exercise. These author’s 
findings support earlier similar work displaying negligible 
changes in protein signaling and synthesis rates in elderly 
males, although this was with supplementation of L-citrul-
line (Churchward-Venne et al. 2014). It could be argued, 
however, that the exercise selected in da Silva et al. (2017) 
was not damaging enough to appropriately assess the recov-
ery of muscle function. Specifically, between 24 and 72 h 
post-exercise the repetitions completed were similar that 
suggests the participants were not sufficiently fatigued at 
the 24-h time point. It is suggested a reduction of between 
15–60% from baseline performance, which can persist for up 
to 2 weeks, is required to suggest exercise-induced muscle 
damage (Owens et al. 2019). In support, the creatine kinase 
concentrations were low (~ 350  UL−1), which compared to 
other literature, values greater than 1000  UL−1 are typically 
seen (Inman et al. 2018; Ehlers et al. 2002). Lastly, the cross-
over trial study design employed by da Silva et al. (2017) is 
arguably not the most appropriate to assess recovery from 
exercise-induced muscle damage; instead, a matched groups 
design could have been used to mitigate the repeated bout 
effect, particularly as da Silva et al. (2017) used recreational 
participants. As a result, based on the limited research to 
date and methodological limitations, further research is 
warranted.
Conclusions and future directions
The lack of positive effects from CM supplementation 
within the existing literature is due to a number of factors, 
including the testing protocols not featuring a predominantly 
aerobic energy contribution, the lack of test–retest reliability 
of exercise protocols, dosing strategy (i.e., amount and tim-
ing), and the recent discovery of quality control issues with 
some manufacturers stated citrulline:malate ratios. Indeed, 
this diversity adds a level of additional noise to our ability 
to draw firm conclusions about the efficacy of CM supple-
mentation on exercise performance or recovery from exhaus-
tive exercise. Nevertheless, from the available evidence, an 
acute 8 g dose CM may, albeit not consistently, increase 
muscular endurance-strength performance (Table 1). This 
corroborates with a recent meta-analysis conducted at the 
time of writing this review, which also reported similar ben-
efits (Vårvik et al. 2021). Whereas, there is little evidence 
to advocate its use in the production and maintenance of 
muscular power, maximal strength, recovery of muscular 
function, or supporting muscular adaptations currently 
(Table 1). Lastly, athletes wishing to explore NO enhanc-
ers are reminded that a good level of evidence exists for 
L-citrulline to improve exercise performance, and therefore 
may consider use of this supplement whilst the intricacies of 
CM supplementation are discovered (Gonzalez and Trexler 
2020).
Future research should investigate the bioavailability of 
key variables, namely plasma NO, citrulline, and arginine 
following a range of doses of CM. Only one study exists 
that has reported this important data at the time of writing 
this review, and this did not include the malate component. 
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Only at this point will the physiologically optimal dose of 
CM become clear. Due to the logistical and cost burden of 
conducting such a study, a simpler approach would be to 
assess various doses of CM (e.g., 8 vs. 10 vs. 12 g CM) on 
an exercise protocol that requires a predominantly aerobic 
energy demand and has high test–retest reliability. Further-
more, manufacturers are required to take more responsibility 
to guarantee that the ratio stated is what is contained within 
the product, and researchers/practitioners should be aware 
of this when sourcing their product for research and/or use 
with athletes. Finally, those who have the resources (primar-
ily manufacturers but also researchers) should analyse the 
purity of the C:M ratio to ensure they have every opportunity 
of achieving an ergogenic effect.
Author contributions LG conceived and designed the research. LG 
wrote the manuscript, with contributions from CAB and SAS. All other 
authors offered critical comments and approved the manuscript.
Declarations 
Conflict of interest The authors declare no conflict of interest.
Open Access This article is licensed under a Creative Commons Attri-
bution 4.0 International License, which permits use, sharing, adapta-
tion, distribution and reproduction in any medium or format, as long 
as you give appropriate credit to the original author(s) and the source, 
provide a link to the Creative Commons licence, and indicate if changes 
were made. The images or other third party material in this article are 
included in the article's Creative Commons licence, unless indicated 
otherwise in a credit line to the material. If material is not included in 
the article's Creative Commons licence and your intended use is not 
permitted by statutory regulation or exceeds the permitted use, you will 
need to obtain permission directly from the copyright holder. To view a 
copy of this licence, visit http:// creat iveco mmons. org/ licen ses/ by/4. 0/.
References
Agudelo LZ, Ferreira DM, Dadvar S, Cervenka I, Ketscher L, Izadi M, 
Ruas JL (2019) Skeletal muscle PGC-1α1 reroutes kynurenine 
metabolism to increase energy efficiency and fatigue-resistance. 
Nat Commun 10(1):1–12
Bahri S, Curis E, El Wafi FZ, Aussel C, Chaumeil JC, Cynober 
L, Zerrouk N (2008) Mechanisms and kinetics of citrulline 
uptake in a model of human intestinal epithelial cells. Clin Nutr 
27(6):872–880
Bendahan D, Mattei JP, Ghattas B, Confort-Gouny S, Le Guern 
ME, Cozzone PJ (2002) Citrulline/malate promotes aerobic 
energy production in human exercising muscle. Br J Sports Med 
36(4):282–289
Breuillard C, Cynober L, Moinard C (2015) Citrulline and nitrogen 
homeostasis: an overview. Amino Acids 47(4):685–691
Casonatto J, Enokida DM, Grandolfi K (2019) Inter-Individual 
Responses to Citrulline Malate Oral Supplementation on Post-
Exercise Hypotension in Hypertensives: A 24-Hour Analysis. Arq 
Bras Cardiol 113(2):218–228
Chappell AJ, Allwood DM, Simper TN (2018a) Citrulline malate fails 
to improve german volume training performance in healthy young 
men and women. J Diet Suppl 21:1–12
Chappell AJ, Allwood DM, Johns R, Brown S, Sultana K, Anand A 
et al (2018b) Citrulline malate supplementation does not improve 
german volume training performance or reduce muscle soreness 
in moderately trained males and females. J Int Soc Sports Nutr 
15(1):8
Churchward-Venne TA, Cotie LM, MacDonald MJ, Mitchell CJ, Prior 
T, Baker SK et al (2014) Citrulline does not enhance blood flow, 
microvascular circulation, or myofibrillar protein synthesis in 
elderly men at rest or following exercise. Am J Physiol 307:83
Cunniffe B, Papageorgiou M, O’Brien B, Davies NA, Grimble GK, 
Cardinale M (2016) Acute citrulline-malate supplementation 
and high-intensity cycling performance. J Strength Cond Res 
30(9):2638–2647
Currell K, Jeukendrup AE (2008) Validity, reliability and sensitivity 
of measures of sporting performance. Sports Med 38:297–316
da Silva DK, Jacinto JL, de Andrade WB, Roveratti MC, Estoche JM, 
Balvedi MCW et al (2017) Citrulline malate does not improve 
muscle recovery after resistance exercise in untrained young adult 
men. Nutrients 9(10):1132
Davis AR, Webber CL, Fish WW, Wehner TC, King S, Perkins-Veazie 
P (2011) L-citrulline levels in watermelon cultigens tested in two 
environments. HortScience 46(12):1572–1575
Ehlers GG, Ball TE, Liston L (2002) Creatine kinase levels are elevated 
during 2-a-day practices in collegiate football players. J Athl Train 
37(2):151
Farney TM, Bliss MV, Hearon CM, Salazar DA (2019) The effect 
of citrulline malate supplementation on muscle fatigue among 
healthy participants. J Strength Cond Res 33(9):2464–2470
Gibala MJ, Young ME, Taegtmeyer H (2000) Anaplerosis of the citric 
acid cycle: role in energy metabolism of heart and skeletal muscle. 
Acta Physiol Scand 168(4):657–665
Gills JL, Glenn JM, Gray M, Romer B, Lu H (2021) Acute citrulline-
malate supplementation is ineffective during aerobic cycling and 
subsequent anaerobic performance in recreationally active males. 
Eur J Sport Sci 18:1–7
Glenn JM, Gray M, Wethington LN, Stone MS, Stewart RW, Moyen 
NE (2017) Acute citrulline malate supplementation improves 
upper- and lower-body submaximal weightlifting exercise per-
formance in resistance-trained females. Eur J Nutr 56(2):775–784
Gonzalez AM, Trexler ET (2020) Effects of citrulline supplementa-
tion on exercise performance in humans: A review of the current 
literature. J Strength Cond Res 34(5):1480–1495
Gonzalez AM, Spitz RW, Ghigiarelli JJ, Sell KM, Mangine GT (2018) 
Acute effect of citrulline malate supplementation on upper-body 
resistance exercise performance in recreationally resistance-
trained men. J Strength Cond Res 32(11):3088–3094
Grimble GK (2007) Adverse gastrointestinal effects of arginine and 
related amino acids. J Nutr 6(2):1693–1701
Hargreaves M, Spriet LL (2020) Skeletal muscle energy metabolism 
during exercise. Nat Metab 2:817–828
Hultström M, Amorim de Paula C, Fontes AP, M., Porcelli, S., Bel-
listri, G., Pugliese, L., et al (2015) Commentaries on Viewpoint: 
Can elite athletes benefit from dietary nitrate supplementation? J 
Appl Physiol 119(6):762–769
Hwang P, Marroquín FEM, Gann J, Andre T, McKinley-Barnard S, 
Kim C et al (2018a) Eight weeks of resistance training in conjunc-
tion with glutathione and L-Citrulline supplementation increases 
lean mass and has no adverse effects on blood clinical safety mark-
ers in resistance-trained males. J Int Soc Sports Nutr 15(1):1–10
Hwang P, Morales Marroquin FE, Gann J, Andre T, McKinley-Bar-
nard S, Kim C et al (2018b) Eight weeks of resistance training 
in conjunction with glutathione and L-citrulline supplementation 
increases lean mass and has no adverse effects on blood clinical 
European Journal of Applied Physiology 
1 3
safety markers in resistance-trained males. J Int Soc Sports Nutr 
15(1):30
Inman LA, Rennie MJ, Watsford ML, Gibbs NJ, Green J et al (2018) 
Reference values for the creatine kinase response to professional 
Australian football match-play. J Sci Med Sport 21(8):852–857
Jones AM, Vanhatalo A, Seals DR, Rossman MJ, Piknova B, Jonvik 
KL (2020) Dietary nitrate and nitric oxide metabolism: mouth, 
circulation, skeletal muscle, and exercise performance. Med Sci 
Sports Exerc 53(2):280–294
Lucero AA, Addae G, Lawrence W, Neway B, Credeur DP, Faulkner 
J, Stoner L (2018) Reliability of muscle blood flow and oxygen 
consumption response from exercise using near-infrared spectros-
copy. Exp Physiol 103(1):90–100
Moinard C, Nicolis I, Neveux N, Darquy S, Benazeth S, Cynober L 
(2008) Dose-ranging effects of citrulline administration on plasma 
amino acids and hormonal patterns in healthy subjects: The citru-
dose pharmacokinetic study. Br J Nutr 99(4):855–862
Owens DJ, Twist C, Cobley JN, Howatson G, Close GL (2019) Exer-
cise-induced muscle damage: What is it, what causes it and what 
are the nutritional solutions? Eur J Sport Sci 19(1):71–85
Perez-Guisado J, Jakeman PM (2010) Citrulline malate enhances 
athletic anaerobic performance and relieves muscle soreness. J 
Strength Cond Res 24(5):1215–1222
Schwedhelm E, Maas R, Freese R, Jung D, Lukacs Z, Jambrecina A 
et al (2008) Pharmacokinetic and pharmacodynamic properties of 
oral L-citrulline and L-arginine: impact on nitric oxide metabo-
lism. Br J Clin Pharmacol 65(1):51–59
Sindelar JJ, Milkowski AL (2012) Human safety controversies sur-
rounding nitrate and nitrite in the diet. Nitric Oxide 26(4):259–266
Stamler JS, Meissner G (2001) Physiology of nitric oxide in skeletal 
muscle. Physiol Rev 81(1):209–237
Takeda K, Machida M, Kohara A, Omi N, Takemasa T (2011) Effects 
of citrulline supplementation on fatigue and exercise performance 
in mice. J Nutr Sci Vitaminol 57(3):246–250
Trexler ET, Persky AM, Ryan ED, Schwartz TA, Stoner L, Smith-Ryan 
AE (2019a) Acute effects of citrulline supplementation on high-
intensity strength and power performance: a systematic review 
and meta-analysis. Sports Med 49(5):707–718
Trexler ET, Keith DS, Schwartz TA, Ryan ED, Stoner L, Persky AM, 
Smith-Ryan AE (2019b) Effects of citrulline malate and beetroot 
juice supplementation on blood flow, energy metabolism, and 
performance during maximum effort leg extension exercise. The 
J Strength Cond Res 33(9):2321–2329
Vanhoutte PM, Zhao Y, Xu A, Leung SW (2016) Thirty years of saying 
NO: sources, fate, actions, and misfortunes of the endothelium-
derived vasodilator mediator. Circ Res 119(2):375–396
Vårvik FT, Bjørnsen T, Gonzalez AM (2021) Acute effect of citrul-
line malate on repetition performance during strength training: 
a systematic review and meta-analysis. Int J Sport Nutrit Exer 
Metabol 1(aop):1–9
Wax B, Kavazis AN, Weldon K, Sperlak J (2015) Effects of sup-
plemental citrulline malate ingestion during repeated bouts of 
lower-body exercise in advanced weightlifters. J Strength Cond 
Res 29(3):786–792
Wax B, Kavazis AN, Luckett W (2016) Effects of supplemental citrul-
line-malate ingestion on blood lactate, cardiovascular dynamics, 
and resistance exercise performance in trained males. J Diet Suppl 
13(3):269–282
Wu JL, Wu QP, Huang JM, Chen R, Cai M, Tan JB (2007) Effects of 
L-malate on physical stamina and activities of enzymes related 
to the malate-aspartate shuttle in liver of mice. Physiol Res 
56(2):213–220
Publisher's Note Springer Nature remains neutral with regard to 
jurisdictional claims in published maps and institutional affiliations.
